Table 1 Modulation of IC molecules in the TME by radiotherapy.

From: Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

IC molecules

Cell types

Changes

Cancer species

RT

Reference

PD-1

CD8+ T cells

↓

Pancreatic cancer

5 Gy × 5

[117]

TAMs

↓

Rectal cancer

2 Gy

[109]

CD4+ T cells CD8+ T cells

↑

Lung cancer

10 Gy × 4

[30]

CD4+ T cells CD8+ T cells

↑

Gastric cancer

5 Gy × 3

[79]

T cells

↑

Prostate cancer

6 Gy

[75]

PD-L1

Tumor cells

↑

Pancreatic cancer

5 Gy × 5

[117]

Tumor cells

↑

Prostate cancer

6 Gy

[75]

Tumor cells

↑

Colon cancer

8 Gy × 3

[120]

Tumor cells

↑

Melanoma

2 Gy × 4

[118]

Tumor cells

↑

Lung cancer

10 Gy × 4

[30]

   

20 Gy

[15]

Tumor cells

↑

Gastric cancer

5 Gy × 3

[79]

Tumor cells

↑

Cervical squamous carcinoma

10 Gy

[121]

Tumor cells

↑

Breast cancer

8 Gy × 3

[15]

   

12 Gy

[86]

TILs

↑

Melanoma

2 Gy × 4

[118]

CD4+ T cells CD8+ T cells

↑

Lung cancer

10 Gy × 4

[30]

CD8+ T cells

↑

HNSCC

10 Gy

[122]

DCs

↑

Lung cancer

10 Gy × 4

[30]

DCs

↑

Breast cancer

12 Gy

[86]

MDSCs

↑

Lung cancer

10 Gy × 4

[30]

Macrophages

↑

Breast cancer

12 Gy

[86]

CTLA-4

iTregs

↓

N/A

10 Gy

[40]

TIGIT

CD8+ T cells

↓

Colon cancer

2 Gy × 18

[120]

CD3+CD4+ T cells CD3+CD8+ T cells

↓

OAC

2 Gy, 4 Gy

[127]

CD8+ T cells

↑

Colon cancer

8 Gy × 3

[120]

TIM-3

CD3+CD4+ T cells CD3+CD8+ T cells

↓

OAC

2 Gy, 4 Gy

[127]

NK cells

↑

Lung and liver cancer

Median: 10 Gy × 5

[31]

CD8+ T cells

↑

HNSCC

10 Gy

[122]

Tregs

↑

HNSCC

10 Gy

[122]

LAG-3

iTregs

↑

N/A

10 Gy

[40]

  1. IC immune checkpoint, RT radiotherapy, PD-1 programmed cell death 1, PD-L1 programmed cell death ligand 1, CTLA-4 cytotoxic T lymphocyte-associated protein 4, TIGIT T cell immunoreceptor with Ig and ITIM domains, TIM-3 T cell immunoglobulin and mucin-containing molecule 3, LAG-3 lymphocyte activation gene 3, TAM tumor-associated macrophage, TIL tumor-infiltrating lymphocyte, DC dendritic cell, MDSC myeloid-derived suppressor cell, Treg regulatory T cell, iTreg induced regulatory T cell, NK natural killer, HNSCC head and neck squamous cell carcinoma, OAC oesophageal adenocarcinoma, N/A not applicable.